Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

On March 5, 2019 Pfizer Inc. reported investors and the general public to view and listen to a webcast of a presentation by Andy Schmeltz, Global President, Oncology, and Chris Boshoff, Chief Development Officer, Oncology, at the Cowen and Company 39th Annual Healthcare Conference on Tuesday, March 12, 2019 at 9:20 a.m. Eastern Daylight Time (Press release, Pfizer, MAR 5, 2019, View Source [SID1234533975]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com/investors beginning today.

Visitors will be able to view and listen to an archived copy of the webcast at www.pfizer.com/investors.

Exelixis Announces Webcasts of Investor Conference Presentations in March

On March 5, 2019 Exelixis, Inc. (NASDAQ: EXEL) reported that the company will be presenting at the following investor conferences in March (Press release, Exelixis, MAR 5, 2019, View Source;p=RssLanding&cat=news&id=2390215 [SID1234533960]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen & Co. 39th Annual Health Care Conference: Exelixis is scheduled to present at 8:00 AM EDT / 5:00 AM PDT on Tuesday, March 12, 2019 in Boston.
Barclays Global Healthcare Conference 2019: Exelixis is scheduled to present at 9:30 AM EDT / 6:30 AM PDT on Wednesday, March 13, 2019 in Miami Beach.
Oppenheimer & Co. 29th Annual Healthcare Conference: Exelixis is scheduled to present at 10:20 AM EDT / 7:20 AM PDT on Tuesday, March 19, 2019 in New York.
To access the webcast links, log onto www.exelixis.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading. Please connect to the company’s website at least 15 minutes prior to each presentation to ensure adequate time for any software download that may be required to listen to the webcasts. Replays will also be available at the same location for 14 days following each presentation.

Relay Therapeutics to Present at Cowen 39th Annual Health Care Conference

On March 5, 2019 Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, reported that Sanjiv K. Patel, M.A., M.D., MBA, president and chief executive officer, will present a company overview at the Cowen 39th Annual Health Care Conference on Monday, March 11, 2019 at 11:30 a.m. ET. The conference is being held March 11-13, 2019 in Boston (Press release, Relay Therapeutics, MAR 5, 2019, View Source [SID1234533976]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!


CytomX to Present at Upcoming Healthcare Conferences

On March 5, 2019 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on our Probody therapeutic technology platform, reported that members of its senior management team will participate at the following healthcare conferences in March (Press release, CytomX Therapeutics, MAR 5, 2019, View Source [SID1234533994]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 39th Annual Health Care Conference

Date: Monday, March 11, 2019
Time: 1:30 p.m. – 2:00 p.m. EST
Location: Boston, Massachusetts

Barclays Global Healthcare Conference

Date: Tuesday, March 12, 2019
Time: 2:05 p.m. – 2:35 p.m. EST
Location: Miami, Florida

Live audio webcast of theses presentations will be available through the "Investors & News" section of CytomX’s website. An archived replay will be available for 90 days following the event.

McKesson Collaborates with Navigating Cancer to Offer Oncologists Enhanced Software Platform for Improved Patient Management in Value-Based Care

On March 5, 2019 Global healthcare leader McKesson Corporation reported a collaboration with technology leader Navigating Cancer to offer an enhanced Patient Relationship Management (PRM) platform for community-based oncologists (Press release, McKesson, MAR 5, 2019, View Source [SID1234554011]). This platform is a comprehensive clinical workflow tool for oncology teams and patients that provides integrated, personalized care. Additionally, it helps providers meet value-based care requirements through features such as patient care management tools, remote monitoring to capture patient-reported outcomes, and a nurse triage tool that includes symptom management pathways. By coordinating tasks that prompt patient involvement, this platform allows physicians and practice staff to focus on what’s most important—caring for patients.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

McKesson is a leader in value-based care, offering a robust suite of products and services to help practices reduce costs, streamline processes, and improve patient care and outcomes. Using Navigating Cancer’s PRM platform gives providers a comprehensive view of patient care, where they are notified of patient-reported outcomes and can triage and provide proactive care in real time. Patients, in turn, have access to personalized information 24/7, have a way to report side effects before they escalate, can receive medication reminders, and ultimately have the opportunity to play a more proactive role in their own care.

"We are excited about working with Navigating Cancer to complement the technology and services we offer to community oncology practices," said Diana Verrilli, senior vice president, Strategy and Practice Solutions, McKesson. "We’re confident the platform will enhance a practice’s ability to coordinate patient care while reducing the administrative burden for staff, creating an exceptional experience for patients and providers."

Coupled with existing McKesson solutions such as the oncology-specific iKnowMed electronic health record (EHR) as well as practice transformation support and education for programs such as the Merit-based Incentive Program (MIPS) and Oncology Care Model (OCM)—Navigating Cancer’s PRM will help oncology practices in their efforts to achieve value-based care.

With more than 1.2 million patient touchpoints each month, Navigating Cancer has been the pioneer in patient relationship management for cancer care since 2008. Navigating Cancer’s oncology-specific software can help care teams stay connected to each other and their patients, improve productivity with streamlined workflows, and, ultimately, provide better care.

"Navigating Cancer’s PRM platform aims to increase access to care and improve care coordination with the goal of improving patient outcomes and decreasing emergency room visits. We have seen this at Rocky Mountain Cancer Centers, Virginia Oncology Associates and Minnesota Oncology, all current iKnowMed customers," said Gena Cook, founder and president, Navigating Cancer. "As a company dedicated to putting patients at the center of their care, we are eager to expand our collaboration with McKesson to significantly impact patient care across the United States."